On-line Enduring Material Teaches on Adrenal Nodules

OSUWexnerbloglogo2014 On-line Enduring Material Teaches on Adrenal Nodules. Pheochromocytomas are fairly rare with about 1,000 cases in the U.S. every year but overall, adrenal tumors are common, and you can find one in about every 20 patients who undergo abdominal CT scans. Most of these adrenal tumors are benign and require no treatment but knowing which ones are consequential and which ones are inconsequential can be a challenge. On this CME webcast, to show you how to manage the incidentally identified adrenal tumor is surgical oncologist and Assistant Professor of Surgery at the Ohio State University, we have Dr. Drew Shirley.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the imaging characteristics used to determine treatment strategies for adrenal nodules; and USE biochemical tests to aid in the diagnosis of functional adrenal nodules.

You’ll also learn about the following:

  • Causes of adrenal nodules
  • Which adrenal nodule need to be biopsied
  • Familial syndromes involving adrenal tumors
  • Incidental adrenal nodules found when staging lung cancer
  • Performing adrenal nodule needle biopsy and FNA
  • What to expect during and after adrenal surgery
  • Approach to adrenal hemorrhage
  • Radiographic imaging follow-up of adrenal nodules
  • Laboratory follow-up of adrenal nodules in patients with hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Teaches on Anticoagulation and New Anticoagulants

OSUWexnerbloglogo2014 Webcast Teaches on Anticoagulation and New Anticoagulants. Now, we have even more anticoagulants and with all of the choices comes a lot of confusion. On this CME webcast, joining our moderator, to demystify all of the new anticoagulants and to give us some direction of when to choose one versus another is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Tzu-Fei Wang.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: State the differences of old anticoagulation and new direct oral anticoagulants and know the four approved direct oral anticoagulant; and UNDERSTAND the indications, laboratory testing, and precautions when prescribing direct oral anticoagulants.

You’ll also learn about the following:

  • The problem with Coumadin
  • Currently available direct oral anticoagulants
  • When Coumadin is the best option
  • Mitigating malpractice risk when prescribing direct oral anticoagulants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.